|
US6303321B1
(en)
|
1999-02-11 |
2001-10-16 |
North Shore-Long Island Jewish Research Institute |
Methods for diagnosing sepsis
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
US7696169B2
(en)
|
2003-06-06 |
2010-04-13 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
WO2005025604A2
(en)
*
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
AU2004272607B2
(en)
|
2003-09-11 |
2008-11-06 |
Cornerstone Therapeutics Inc. |
Monoclonal antibodies against HMGB1
|
|
EP1768677B1
(en)
*
|
2004-07-02 |
2008-06-25 |
Creabilis Therapeutics S.P.A. |
Nucleic acids for the treatment of hmgb1-related pathologies
|
|
WO2006012373A2
(en)
*
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Combination therapies of hmgb and complement inhibitors against inflammation
|
|
JP5622351B2
(ja)
*
|
2004-09-03 |
2014-11-12 |
クレアビリス・セラピューティクス・エスピーエー |
プロテアーゼ抵抗性ヒトおよび非ヒトＨＭＧＢ１Ｂｏｘ−Ａ変異体、ならびにそれらの治療／診断への使用
|
|
WO2007001422A2
(en)
*
|
2004-10-22 |
2007-01-04 |
Medimmune, Inc. |
High affinity antibodies against hmgb1 and methods of use thereof
|
|
EP1899376A2
(en)
*
|
2005-06-16 |
2008-03-19 |
The Feinstein Institute for Medical Research |
Antibodies against hmgb1 and fragments thereof
|
|
WO2007011606A2
(en)
*
|
2005-07-18 |
2007-01-25 |
Critical Therapeutics, Inc. |
USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
|
|
WO2007031100A1
(en)
*
|
2005-09-14 |
2007-03-22 |
Ostini, Marco |
Active immunotherapy of life-threatening systemic inflammation
|
|
EP1957534A1
(en)
*
|
2005-11-09 |
2008-08-20 |
Pharmexa A/S |
Therapeutic vaccines targeting hmgb1
|
|
CA2663300C
(en)
*
|
2006-09-15 |
2014-10-07 |
Creabilis Therapeutics S.P.A. |
Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
|
|
PL2066339T3
(pl)
|
2006-09-18 |
2015-02-27 |
Univ Arkansas |
Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
|
|
JP5225109B2
(ja)
|
2007-02-15 |
2013-07-03 |
国立大学法人 熊本大学 |
ヒトｈｍｇｂ−１に特異的に結合する抗体を有効成分として含有する治療剤
|
|
JP5676253B2
(ja)
|
2008-04-30 |
2015-02-25 |
株式会社ジェノミックス |
生体内機能的細胞の高効率採取法
|
|
JP5865703B2
(ja)
|
2009-10-28 |
2016-02-17 |
株式会社ジェノミックス |
骨髄間葉系および／または多能性幹細胞の血中動員による組織再生促進剤
|
|
ES2643646T3
(es)
|
2010-01-21 |
2017-11-23 |
The Board Of Trustees Of The University Of Arkansas |
Vectores de vacuna y métodos para potenciar las respuestas inmunitarias
|
|
MX350306B
(es)
|
2010-06-09 |
2017-09-04 |
Univ Arkansas |
Vacuna y metodos para reducir una infeccion por campylobacter.
|
|
PT3358011T
(pt)
|
2011-04-26 |
2020-04-23 |
Univ Osaka |
Péptido para induzir a regeneração de um tecido e a sua utilização
|
|
ES2660420T3
(es)
|
2012-10-25 |
2018-03-22 |
Genomix Co., Ltd. |
Método novedoso para tratar infarto cardiaco utilizando fragmento de HMGB1
|
|
US9688733B2
(en)
*
|
2012-10-25 |
2017-06-27 |
Genomix Co., Ltd. |
Method for treating spinal cord injury using HMGB1 fragment
|
|
CA2897914A1
(en)
|
2013-01-28 |
2014-07-31 |
Evec Inc. |
Humanized anti-hmgb1 antibody or antigen-binding fragment thereof
|
|
AR094791A1
(es)
|
2013-02-14 |
2015-08-26 |
Univ Arkansas |
Composiciones y métodos para mejorar las respuestas inmunes ante una infección por eimeria o para limitar una infección por eimeria
|
|
AU2014239557B2
(en)
|
2013-03-15 |
2019-01-03 |
The Board Of Trustees Of The University Of Arkansas |
Compositions and methods of enhancing immune responses to enteric pathogens
|
|
KR102767638B1
(ko)
|
2016-05-03 |
2025-02-20 |
더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 |
면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법
|
|
EP3556378B1
(en)
|
2017-01-27 |
2025-03-12 |
StemRIM Inc. |
Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure
|
|
WO2018170178A1
(en)
|
2017-03-15 |
2018-09-20 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
|
CN111868231B
(zh)
|
2017-12-01 |
2024-05-31 |
斯特姆里姆有限公司 |
外胚层间充质干细胞及其产生方法
|
|
CN111542335A
(zh)
*
|
2017-12-01 |
2020-08-14 |
斯特姆里姆有限公司 |
炎症性肠病的治疗药
|
|
US20210024594A1
(en)
*
|
2018-02-08 |
2021-01-28 |
StemRIM Inc. |
Therapeutic Agent for Psoriasis
|
|
US12304933B2
(en)
|
2018-10-05 |
2025-05-20 |
StemRIM Inc. |
Disease treatment drug based on mesenchymal-stem-cell mobilization
|
|
AU2019354829B2
(en)
*
|
2018-10-05 |
2025-04-17 |
Research Institute At Nationwide Children's Hospital |
Hmgb1 protein derivatives for the removal of biofilms
|
|
CN111743890A
(zh)
*
|
2019-03-26 |
2020-10-09 |
深圳先进技术研究院 |
水绫霉素或其衍生物的用途
|